MONTHLY FUND UPDATE OCT 2020 - PUBLICATION BY - University of St. Andrews ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
PUBLICATION BY PREPARED BY ST ANDREWS INVESTMENT SOCIETY JASMIN ESERMANN MONTHLY FUND UPDATE OCT 2020
PAGE | 02 ST ANDREWS INVESTMENT SOCIETY GENERAL PORTFOLIO 1M: -3.04% ▼ 3M: -3.21% ▼ OVERVIEW 12M: +0.20% ▲ Renewed market volatility in the month of restrictions were further reinstated across October led to a 3.04% drop in portfolio Europe to curb the accelerating second performance, compared to a 2.77% decline wave of coronavirus cases. of the S&P500 index. Selling intensified towards the end of the The hardest hit sector of the portfolio was month, with global equities suffering the Health Care & Pharmaceuticals, posting a worst trading week since March. Factors 1.60% loss, whereas the Technology, such as mounting virus concerns and the Media & Telecommunications sector was outcome of the US presidential elections among the more resilient with a gain of caused the broader market to end in 0.10%. negative territory. Following a tough September, the market The fear-gauge CBOE Volatility Index was off to a good start with optimism of (VIX) climbed close to 40 in the week additional fiscal stimulus, driving the before the US election, doubling its long-run market higher and the S&P500 hitting a average. high for the month on 12 October, gaining Mega-cap tech firms provided a weaker- 5%. than-expected outlook, causing Apple However, equities fell by 2.4% for a shares to drop 6% as iPhone revenue second consecutive month, with faded missing analysts’ estimates, while Twitter investor optimism and a blurred path of closed down more than 20.6%, following economic recovery ahead, as disappointing new-user numbers. widespread 52-Week Portfolio Performance Relative to S&P500 Benchmark
PAGE | 03 ST ANDREWS INVESTMENT SOCIETY OUTLOOK As the prospect of a rosy “V-shaped” recovery appears less certain, analysts estimate weak growth in the coming months ahead. The global economy is predicted to shrink 4.4% this year, with global debt expected to reach a record $277 trillion by year’s end (as reported by the Institute of International Finance), as local economies continue to rely on government coronavirus relief. Promising results on successful Phase 3 trials by drugmakers Pfizer and Moderna have heightened optimism that an effective vaccine will be available in the coming months, however it will be 2022 before we have ‘semblances of normality’, warns Fauci. Deal or no-deal? Post-Brexit discussions are underway to reach a trade agreement following the end of the transition period on Jan 1, 2020, with raised optimism that a deal will be struck, yet ‘significant differences’ between the two sides remain and failure to bridge the gaps may cause talks to collapse. China’s GDP expands beyond pre-pandemic levels, with industrial output higher than expected, up 6.9% YOY, standing out in a shrinking global trade. The country is the only major economy with predicted positive GDP growth this year.
PAGE | 04 ST ANDREWS INVESTMENT SOCIETY Sector Exposure - October 2020 Best and Worst Performing Stocks 02
PAGE 03 PAGE | 05 ST ANDREWS INVESTMENT SOCIETY SECTOR SPOTLIGHT Healthcare & Pharmaceuticals Becton Dickinson and Co. (NYSE: BDX) With the largest sector allocation holding of 35%, the sharp losses of Health Care & Pharmaceuticals equities in the portfolio (-1.48%) helped drag the portfolio performance lower throughout October. Becton Dickinson & Co. (NYSE: BDX), an American medical technology company, is currently trading around $230 and fell 1.48% last month, still -13.27% lower YTD. While BD has underperformed the market this year, the company is currently profiting from strong Covid-19 diagnostic testing sales, as indicated by the 11.60% earnings surprise of the latest quarter, with EPS of $2.79 compared to the estimated $2.50 per share. Additionally, Canada is purchasing 7.6 mil rapid Covid-19 tests from the company, with early shipments likely to begin in late November. Further, the Dutch ministry of Health purchased 9.2 million antigen tests from Becton Dickinson early this month. Additional growth opportunities include the C.R. Bard acquisition at the end of 2017, which has resulted in a significant share count increase, as well as the recently announced purchase of Medical Business Assets of CUBEX, which will expand the company’s medication management offerings.
PAGE 03 PAGE | 06 ST ANDREWS INVESTMENT SOCIETY SECTOR SPOTLIGHT Financial & Professional Services Evercore Inc. (NYSE: EVR) Stocks of the Financial & Professional Services sector were impacted by the strong sell-off in the final days of October, with returns down 0.86% over the past month, following a 0.91% increase by mid-October. Evercore Inc. (NYSE: EVR), a global independent investment banking advisory firm founded in 1995, has seen its stock rise 11% over the last 12 months, currently trading higher than pre-Covid-19 levels. The investment bank’s Q3 EPS of $1.11 beat analysts’ estimates of $0.37 per share, creating an earnings surprise of 200% and continuing the impressive record of positive earnings over the last four quarters. Revenues remained stable at $408.5 million in the last quarter, as higher underwriting revenues (195% increase versus previous year) were offset by decreases in advisory fees, commissions and related fees. The S&P Global Ratings agency has placed a “negative” outlook for a third of global banks for 2021, with slow recovery due to potential further economic disruption by reinstated lockdown measures, fewer support measures once fiscal support subsides and the impact of a weakening property market. Yet improvements in credit conditions, a steepened yield curve as well as a successful vaccine will prove favourable for financial stocks.
PAGE 03 PAGE | 07 ST ANDREWS INVESTMENT SOCIETY SECTOR SPOTLIGHT Industrials & Natural Resources Cheniere Energy, Inc. (NYSEAmerican: LNG) The Industrials & Natural Resources sector, comprising 11.68% of the portfolio, remained relatively stable throughout the month of October (-0.01%). US industrial output accelerated more than expected last month, rising 1.1%, yet remains well below pre-pandemic levels. Cheniere Energy (NYSEAmerican: LNG), the Houston-based leading producer and exporter of liquefied natural gas, reported steep Q3 losses amounting to $463 million, while revenues were down 32.7% from $2.17 billion reported in the previous year. The stock rose 9.81% in mid-October, trading at $50.89, before it dropped sharply towards the end of the month to $47.87 – securing a monthly 3.30% gain Stable operations and increased production rates provide robust financial guidance for Cheniere Energy in 2021. The company plans to complete the third train at its liquefied natural gas export plant in South Texas in the first quarter of 2021, “ahead of schedule” and within budget. In addition, China’s first term deal to purchase liquefied natural gas from Cheniere Energy since the disrupted trade war, indicates confidence of improved relations between the world’s two most powerful economies. Natural gas has an increasingly important role to play in the global transition to a lower carbon future as a cleaner energy source, hence rising global LNG demand and long-term contracts places the stock in a favourable position for steady future growth.
PAGE 03 PAGE | 08 ST ANDREWS INVESTMENT SOCIETY SECTOR SPOTLIGHT Consumer Goods & Services Unilever PLC (LSE:ULVR) Retail sales in the US last month climbed at the slowest pace in six months, up 0.3% compared to an expected 0.5%. Negative returns of 0.36% of the Consumer Goods & Services sector within the portfolio suggest hesitant consumer spending amidst rising virus concerns and declining household income. Anglo-Dutch packaged consumer goods giant, Unilever (LSE: ULVR), which has a market cap of £118Bn, has a diversified product portfolio reaching 2.5Bn customers across the globe, including heavy exposure to emerging economies. Shares have risen 8% since the beginning of the year. The group, which owns Marmite, Dove and Wall’s, reported a 4.4% increase of year-on-year organic growth to £11.6 billion, beating consensus estimates of 1.3%, despite currency headwinds. However, CEO Alan Jope warned that outlook remains uncertain and was “perplexed by talk of a quick recovery”. Investor’s worries were reflected in the 4% drop of Unilever shares since the beginning of the week (24 October). The surge in sales of the FTSE100 giant was largely driven by emerging markets, comprising around 60% of the company’s revenue, while e-commerce sales surged 76% during the quarter·. Unilever announced this week it is expanding sales of its vegan and dairy-free products, targeting a five-fold increase to €1bn by 2027, as it seeks to profit by the growing consumer trend towards reducing meat and dairy intake. The drive for plant-based alternatives will be led by the Dutch-based The Vegetarian Butcher brand, acquired in 2018, which is said to be growing “explosively”.
PAGE 03 PAGE | 09 ST ANDREWS INVESTMENT SOCIETY SECTOR SPOTLIGHT Technology, Media & Telecommunications Alibaba Group Holding Ltd.(NYSE: BABA) The Technology, Media & Telecommunications sector, comprising 20% of the portfolio, posted the highest sector return in October as well as a three-month increase of 2.80%. Jack Ma’s e-commerce giant Alibaba (NYSE: BABA), currently trading at $255.69, operates through four business segments: core commerce, cloud computing, digital media & entertainment, and innovation initiatives and others. Alibaba currently controls 56% of China’s e-commerce market as well as 40.1% of China’s cloud infrastructure market. Revenues in the third quarter rose 30% to $22.8 billion, yet fell short of analyst expectations. Similar to other tech firms, Alibaba is profiting from the e-commerce momentum triggered by the pandemic, as well as the booming cloud computing business, which saw revenues surge 60% YOY growth in the last quarter A notable headwind is the suspended IPO of the financial technology firm Ant Group, co-founded by Jack Ma, which was on track to raise over $34 billion in the world’s largest-ever share sale. The interrupted public offering by the Shanghai Stock Exchange as a result of new regulations, will cause Ant Group to function more as a bank, rather than a technology company, which will tremendously. downsize the predicted valuation and affect the financial performance of Alibaba· Whilst Alibaba continues to pursue a unique growth strategy, such as the three- year experiment Xunxi (“Fast Rhino”) Digital Factory to modernize China’s manufacturing sector, as well as the joint $1.1Bn investment with Swiss luxury group Richemont in the UK-based online retailer Farfetch, tailwinds such as ominous government regulations for anticompetition may be impactful on the Alibaba stock.
Contact the FMT for more information: Email: fmt@sta-investsoc.com Website: www.sta-investsoc.com Victor Gong Robbie Turnbull Head of Fund President of Investment Society FPS Sector Coverage EMK Sector Coverage Jasmin Esermann Jackson Stafford Head of Investor Relations Head of Operations CGS Sector Coverage HCP Sector Coverage Nathalie Nourry Head of ESG TMT Sector Coverage Daniel Khajenouri Head of ESG INR Sector Coverage
You can also read